tirzepatide therapy san antonio The Trim Texan Weight Loss – The Trim Texan Weight Loss clinic in Tirzepatide Weight Loss Injection -

March 2024 : The US FDA approved a label expansion for WEGOVY based on a supplemental New Drug Application (sNDA) for the indication of reducing risks of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack (myocardial infarction), or non-fatal stroke in adults with either overweight or obesity and established CVD

Perhaps even more telling, tirzepatide users had lower rates of NSAID and opioid prescriptions compared to users of other weight loss medications

This makes the peptide more suitable for those concerned about cardiovascular health or those who found GH fluid retention problematic

Farizi, Jeanette Bannebjerg Johansen, Sanne L

2022 Nov 30

Good candidates are people with a thin upper lip, a lip that disappears when smiling, or those who want subtle enhancement without added volume